This is a paid message on behalf of FendX Technologies Inc.
Although the COVID pandemic created numerous challenges for the global economy, it facilitated the advancement of several industries.
From hand sanitizers to nanotechnology products, the pandemic has been a catalyst for the production of cleaning solutions and supplies. The world is better prepared for another pandemic and we have been focused on identifying companies that would benefit in the event of a recurrence.
After conducting months of research, we have identified a company that is focused on developing products to make people’s lives safer by reducing the spread of pathogens. From forming strategic partnerships to strengthening its intellectual property (IP) portfolio, the company is executing on a multi-faceted growth strategy, and we are bullish on the direction the management team is bringing the business.
The company, FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D), is a Canadian- based nanotechnology company which is laser focused on developing products that aim to reduce the spread of pathogens. Currently, the company is working to develop both film and spray coatings to protect surfaces prone to contamination and we are favorable on the diversity of the business.
About FendX
We believe that FendX is in the early innings of a potential major growth cycle and want our readers to be aware of the opportunity. Over the next year, we anticipate the company to report a series of positive developments and we want to be ahead of this. Some of the reasons for our favorable view on the business include:
- FendX has secured strategic partnerships which we expect will play an important role in the growth of the business.
- The company has several potential growth catalysts, and we believe the market under-appreciates this aspect of the story.
- The management team is focused on execution, and we believe the team is working to create value for shareholders.
- At current levels, we believe the business is undervalued and has a favorable risk-reward profile.
FendX’s lead product under development is called REPELWRAP™ film. The product is a protective surface coating film that significantly reduces the adhesion of pathogens and reduces their transmission on surfaces which are prone to contamination. The company is in the process of conducting research and development (R&D) activities with its nanotechnology and is working with various strategic partners.
REPELWRAP™ film is a protective surface coating film that leverages its award-winning nanotechnology. Going forward, the company believes REPELWRAP™ film will have applications in healthcare settings and in other industries. We are favorable on the number of industries that can benefit from the technology and consider this to be an undervalued part of the business.
One of FendX’s strategic partners is McMaster University. We are favorable on the work that has already been accomplished through the relationship and expect additional milestones to be reported later this year. The company entered into license agreements that provides FendX with an exclusive worldwide license to McMaster’s technology and intellectual property (IP) portfolio which encompasses both film and spray coating nanotechnology formulations.
An Emerging Growth Story
A few weeks ago, FendX reported to have entered into a Collaborative Research Agreement (CRA) with McMaster University which covers the R&D strategy for the spray coating formulation that was licensed by it.
The development of the spray formulation is an important addition to FendX’s nanotechnology product pipeline. Due to the formulation being in a spray format, the product has the potential to be more readily applied to high-touch surfaces and may allow the company to expand its total addressable market (TAM) once it’s commercialized.
We expect the development of the spray formulation will also strengthen FendX’s overall IP portfolio and believe the market undervalues this aspect of the business. We consider McMaster to be a strategic partner and are bullish on the growth prospects that are associated with the relationship and the spray technology.
By collaborating with the lead researchers and with McMaster, FendX has access to human capital which has a significant amount of expertise when it comes to the development of the spray coating formula. We consider the human capital from McMaster to be an unappreciated part of the story and want our readers to be aware of its significance
In June, FendX announced a milestone and reported to have successfully completed the first phase of development outlined in the development stage agreement with Dunmore International Corp., a Steel Partners Holdings L.P. (NYSE: SPLP) operating company which was announced in April.
Pursuant to the development stage agreement, the first phase was for Dunmore to adapt to its manufacturing production processes McMaster’s lab prototype formulation for making REPELWRAP™ film. The successful replication confirms the compatibility of FendX’s formula with Dunmore’s production processes and we are favorable on this. The films created at Dunmore were then tested at McMaster which confirmed the films to have similar repelling properties to the lab prototype.
This development marks a significant step forward in FendX’s scale-up initiatives. During the next step, Dunmore will conduct small runs on their commercial manufacturing line to create intermediate sized films for further testing. Once the manufacturing process can be automated, FendX will have accomplished a key first step in advancing development toward a potential the commercialization process and we will monitor how the process advances.
Led By a Management Team with a Proven Track Record
When it comes to analyzing any company, the management team is one of the first parts of the business that we explore. When it comes to FendX, we believe the company is led by a leadership team that has a proven track record of success and a diverse mix of expertise. We consider the combination of a proven track record and diverse expertise to be a recipe for success and are bullish on how the business has advanced over the last year.
At the helm of FendX is Dr. Carolyn Myers, MBA, PhD, who serves as the President, Chief Executive Officer, and a Director. She is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. We are favorable on the experience and expertise that Dr. Myers brings to FendX.
Another key member of the team is Chief Operating Officer Andrea Mulder. She is an accomplished senior commercial healthcare executive with extensive sales and marketing experience leading launch strategies at leading pharmaceutical and biotechnology corporations in Canada. She has significant knowledge across multiple therapeutic areas including infectious disease, immunology, neurology, respiratory and oncology and has been an active member of several global and Canadian leadership/commercial teams.
An Opportunity That is Flying Under the Radar
Over the next year, we expect FendX to accomplish several key milestones and believe the business is in the early stages of a major growth cycle and will monitor how the management team is able to further advance the opportunity.
We believe that FendX’s total addressable market could be massive and consider this to be important part of the long- term growth story. By forming strategic relationships, the company is better positioned to capture market share and we believe the market does not fully appreciate this aspect of the story.
In the near-term, we expect FendX’s relationship with McMaster to play an important role in the advancement of the business. We are bullish on the growth prospects that are associated with this relationship and want our readers to be aware of its significance.
Company Relationship Disclosure
OTB is responsible for the OTB opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and OTB does not undertake to confirm or substantiate or be responsible for such information provided by other parties.
Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.
Pursuant to an agreement between Spotlight Media and FendX Technologies Inc. we have been hired for a period of 30 days beginning August 1, 2023 and ending September 1, 2023 to publicly disseminate information about FendX Technologies Inc. including on the Website and other media including Facebook and Twitter. We are being paid $3,500 per month by FendX Technologies Inc. and were paid “ZERO” shares of unrestricted or restricted common shares. We may buy or sell additional shares of FendX Technologies in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
FendX Technologies Inc. Forward Looking Statement:
Certain statements contained in these marketing materials constitute forward-looking information and statements within the meaning of applicable securities laws (collectively, “forward-looking statements”). These statements relate to future events or the future performance of FendX Technologies Inc. (“FendX” or the “Company”). All statements other than statements of historical fact are forward-looking statements. The use of any of the words “anticipate”, “plan”, “aim”, “target”, “contemplate”, “continue”, “estimate”, “expect”, “intend”, “propose”, “might”, “may”, “will”, “shall”, “project”, “should”, “could”, “would”, “believe”, “predict”, “forecast”, “pursue”, “potential”, “possible”, and similar expressions are intended to identify forward-looking statements. Forward-looking statements, included or referred to in these marketing materials include, but are not limited to statements with respect to: the business and financial prospects and opportunities of FendX; expectations regarding industry trends, overall market growth rates and FendX’s growth rates and growth strategies; the performance of FendX’s business and operations, including its research and development and scale up initiatives; FendX’s expectations regarding commercialization; FendX’s expectations regarding revenues, expenses and anticipated cash needs; FendX’s expectations regarding its target markets and industries; FendX’s intention to grow its business, operations and intellectual property portfolio; the expected timing and completion of FendX’s near-term objectives; laws and regulations and any amendments thereto applicable to FendX, its business, operations and financial results; FendX’s competitive advantages and business strategies; and other assumptions inherent in management’s expectations in respect of the forward-looking statements identified herein.
The forward-looking statements reflect FendX’s beliefs and assumptions with respect to, among other things, future operating and financial results; the accuracy of financial and operational projections; the impact of the international or global events, including government responses related thereto on demand for FendX’s products and FendX’s operations generally; general economic and industry conditions; future growth in world-wide demand for FendX’s products; FendX’s ability to obtain and retain qualified and diverse personnel in a timely and cost-efficient manner or at all; the regulatory framework governing FendX’s operations in the jurisdictions in which FendX conducts and will conduct its business; the development and performance of new products and technology; FendX’s ability to obtain financing on acceptable terms; inflation and changes to interest rates and their impact on FendX; the impact of increasing competition on FendX; the impact of changes in government policies on FendX; FendX’s ability to generate sufficient cash flow to meet its current and future obligations; product supply and demand; FendX’s ability to successfully implement the plans and programs disclosed in FendX’s strategy and other assumptions inherent in management’s expectations in respect of the forward-looking statements identified herein.
The forward-looking statements contained in this document represent FendX’s expectations as of the date hereof and are subject to change after such date. FendX disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as may be required by applicable laws. Readers are cautioned that the foregoing lists are not exhaustive. For a full discussion of our material risk factors, see “Risk Factors” in FendX’s management’s discussion and analysis for the three months ended March 31, 2023, and “Risk Factors” in FendX’s long form prospectus dated January 31, 2023, each as filed on SEDAR+ at www.sedarplus.ca.
Additional Disclosures
This is a paid advertisement on behalf of FendX Technologies Inc.
Certain statements contained in these marketing materials constitute forward-looking information and statements within the meaning of applicable securities laws (collectively, “forward-looking statements”). These statements relate to future events or the future performance of FendX Technologies Inc. (“FendX” or the “Company”). All statements other than statements of historical fact are forward-looking statements. The use of any of the words “anticipate”, “plan”, “aim”, “target”, “contemplate”, “continue”, “estimate”, “expect”, “intend”, “propose”, “might”, “may”, “will”, “shall”, “project”, “should”, “could”, “would”, “believe”, “predict”, “forecast”, “pursue”, “potential”, “possible”, and similar expressions are intended to identify forward-looking statements. Forward-looking statements, included or referred to in these marketing materials include, but are not limited to statements with respect to: the business and financial prospects and opportunities of FendX; expectations regarding industry trends, overall market growth rates and FendX’s growth rates and growth strategies; the performance of FendX’s business and operations; FendX’s expectations regarding revenues, expenses and anticipated cash needs; FendX’s intention to grow its business and operations; the expected timing and completion of FendX’s near-term objectives; laws and regulations and any amendments thereto applicable to FendX, its business, operations and financial results; FendX’s competitive advantages and business strategies; and other assumptions inherent in management’s expectations in respect of the forward-looking statements identified herein.
The forward-looking statements reflect FendX’s beliefs and assumptions with respect to, among other things, future operating and financial results; the accuracy of financial and operational projections; the impact of the international or global events, including government responses related thereto on demand for FendX’s products and FendX’s operations generally; general economic and industry conditions; future growth in world-wide demand for FendX’s products; FendX’s ability to obtain and retain qualified and diverse personnel in a timely and cost-efficient manner or at all; the regulatory framework governing FendX’s operations in the jurisdictions in which FendX conducts and will conduct its business; the development and performance of new products and technology; FendX’s ability to obtain financing on acceptable terms; inflation and changes to interest rates and their impact on FendX; the impact of increasing competition on FendX; the impact of changes in government policies on FendX; FendX’s ability to generate sufficient cash flow to meet its current and future obligations; product supply and demand; FendX’s ability to successfully implement the plans and programs disclosed in FendX’s strategy and other assumptions inherent in management’s expectations in respect of the forward-looking statements identified herein.
The forward-looking statements contained in this document represent FendX’s expectations as of the date hereof and are subject to change after such date. FendX disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as may be required by applicable laws. Readers are cautioned that the foregoing lists are not exhaustive. For a full discussion of our material risk factors, see “Risk Factors” in FendX’s management’s discussion and analysis for the three months ended March 31, 2023, and “Risk Factors” in FendX’s long form prospectus dated January 31, 2023, each as filed on SEDAR+ at www.sedarplus.ca.
